ATE452882T1 - Herstellung von quetiapin - Google Patents
Herstellung von quetiapinInfo
- Publication number
- ATE452882T1 ATE452882T1 AT04767074T AT04767074T ATE452882T1 AT E452882 T1 ATE452882 T1 AT E452882T1 AT 04767074 T AT04767074 T AT 04767074T AT 04767074 T AT04767074 T AT 04767074T AT E452882 T1 ATE452882 T1 AT E452882T1
- Authority
- AT
- Austria
- Prior art keywords
- quetiapine
- preparation
- compound
- discloses
- well
- Prior art date
Links
- URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004431 quetiapine Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50498103P | 2003-09-23 | 2003-09-23 | |
| PCT/FI2004/000560 WO2005028458A1 (en) | 2003-09-23 | 2004-09-23 | Preparation of quetiapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452882T1 true ATE452882T1 (de) | 2010-01-15 |
Family
ID=34375548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04767074T ATE452882T1 (de) | 2003-09-23 | 2004-09-23 | Herstellung von quetiapin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7863441B2 (de) |
| EP (1) | EP1664007B1 (de) |
| JP (1) | JP2007505864A (de) |
| AT (1) | ATE452882T1 (de) |
| CA (1) | CA2538745A1 (de) |
| DE (1) | DE602004024798D1 (de) |
| ES (1) | ES2335589T3 (de) |
| PT (1) | PT1664007E (de) |
| WO (1) | WO2005028458A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007505865A (ja) * | 2003-09-23 | 2007-03-15 | フェルミオン オサケ ユキチュア | クエチアピンの製造 |
| JP2008502707A (ja) | 2005-04-14 | 2008-01-31 | テバ ファーマシューティカル インダストリーズ リミティド | クエチアピンフマレートの調製方法 |
| PT103884A (pt) * | 2006-11-17 | 2008-05-19 | Astrazeneca Ab | Composições de libertação prolongada e métodos para a sua preparação |
| WO2009004480A2 (en) | 2007-05-07 | 2009-01-08 | Actavis Group Ptc Ehf | Quetiapine salts and their polymorphs |
| CA2711395A1 (en) | 2008-01-31 | 2009-08-06 | Fermion Oy | A process for the preparation of quetiapine |
| WO2010100623A1 (en) | 2009-03-04 | 2010-09-10 | Ranbaxy Laboratories Limited | Process for the preparation of quetiapine fumarate |
| CN101891707B (zh) * | 2010-07-29 | 2012-10-17 | 浙江海正药业股份有限公司 | 喹硫平或其可药用盐的制备方法 |
| ES2701062T3 (es) * | 2012-08-21 | 2019-02-20 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
| JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス，インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| ES3057437T3 (en) | 2012-08-21 | 2026-03-02 | Janssen Pharmaceutica Nv | Antibodies to olanzapine haptens and use thereof |
| AU2013305970B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to aripiprazole haptens and use thereof |
| EP2888277A4 (de) | 2012-08-21 | 2016-05-18 | Ortho Clinical Diagnostics Inc | Antikörper gegen paliperidon und verwendung davon |
| ES2870004T3 (es) | 2012-08-21 | 2021-10-26 | Janssen Pharmaceutica Nv | Anticuerpos contra la risperidona y uso de los mismos |
| PL2888373T3 (pl) | 2012-08-21 | 2018-08-31 | Janssen Pharmaceutica Nv | Przeciwciała dla arypiprazolu i ich zastosowanie |
| PT3305784T (pt) * | 2012-08-21 | 2020-10-23 | Janssen Pharmaceutica Nv | Haptenos de quetiapina para utilização em ensaios imunológicos |
| WO2014031645A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to risperidone haptens and use thereof |
| PL2888286T3 (pl) | 2012-08-21 | 2018-07-31 | Janssen Pharmaceutica Nv | Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie |
| ES2654413T3 (es) | 2012-08-21 | 2018-02-13 | Janssen Pharmaceutica, N.V. | Anticuerpos a quetiapina y uso de los mismos |
| WO2014031662A2 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine and use thereof |
| WO2014031584A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of aripiprazole and their use in immunoassays |
| AU2013305930B2 (en) | 2012-08-21 | 2017-08-24 | Saladax Biomedical Inc. | Haptens of paliperidone |
| CA2882560C (en) | 2012-08-21 | 2020-10-27 | Ortho-Clinical Diagnostics, Inc. | Haptens of risperidone and paliperidone for use in immunoassays |
| CN103396382B (zh) * | 2013-07-29 | 2015-05-20 | 太仓市茜泾化工有限公司 | 一种喹硫平中间体的制备方法 |
| CN104803947A (zh) * | 2015-03-12 | 2015-07-29 | 常州康丽制药有限公司 | 11-(1-哌嗪基)二苯并[b,f][1,4]硫氮杂*富马酸盐的制备方法 |
| JP6949025B2 (ja) | 2015-12-17 | 2021-10-13 | ヤンセン ファーマシューティカ エヌ．ベー． | リスペリドンに対する抗体及びその使用 |
| CN108368180B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 喹硫平的抗体及其用途 |
| CN114181172B (zh) * | 2021-12-27 | 2023-12-22 | 浙江苏泊尔制药有限公司 | 一种富马酸喹硫平的高效制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA979441A (en) * | 1967-02-27 | 1975-12-09 | American Cyanamid Company | 11-(piperazinyl) dibenz (b,f) (1,4) oxazepines and analogous thiazepines |
| US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| HU227039B1 (en) * | 2000-01-25 | 2010-05-28 | Egis Gyogyszergyar Nyilvanosan | New process for the production of quetiapine and intermediates therefor |
| KR20100008794A (ko) * | 2001-04-16 | 2010-01-26 | 쉐링 코포레이션 | Ｃｘｃ-케모카인 수용체 리간드로서의 3,4-이치환된 사이클로부텐-1,2-디온 |
| ES2223294B2 (es) * | 2003-08-08 | 2005-10-01 | Vita Cientifica, S.L. | Procedimiento de preparacion de un compuesto farmaceuticamente activo. |
| JP2007505865A (ja) | 2003-09-23 | 2007-03-15 | フェルミオン オサケ ユキチュア | クエチアピンの製造 |
-
2004
- 2004-09-23 PT PT04767074T patent/PT1664007E/pt unknown
- 2004-09-23 US US10/572,409 patent/US7863441B2/en not_active Expired - Fee Related
- 2004-09-23 ES ES04767074T patent/ES2335589T3/es not_active Expired - Lifetime
- 2004-09-23 JP JP2006526653A patent/JP2007505864A/ja not_active Ceased
- 2004-09-23 WO PCT/FI2004/000560 patent/WO2005028458A1/en not_active Ceased
- 2004-09-23 EP EP04767074A patent/EP1664007B1/de not_active Expired - Lifetime
- 2004-09-23 DE DE602004024798T patent/DE602004024798D1/de not_active Expired - Lifetime
- 2004-09-23 CA CA002538745A patent/CA2538745A1/en not_active Abandoned
- 2004-09-23 AT AT04767074T patent/ATE452882T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| PT1664007E (pt) | 2010-02-15 |
| EP1664007A1 (de) | 2006-06-07 |
| US7863441B2 (en) | 2011-01-04 |
| DE602004024798D1 (de) | 2010-02-04 |
| US20070111987A1 (en) | 2007-05-17 |
| EP1664007B1 (de) | 2009-12-23 |
| ES2335589T3 (es) | 2010-03-30 |
| CA2538745A1 (en) | 2005-03-31 |
| JP2007505864A (ja) | 2007-03-15 |
| WO2005028458A1 (en) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004024798D1 (de) | Herstellung von quetiapin | |
| BR0307432B1 (pt) | difluormetiltiazolilcarboxanilidas | |
| CY1110064T1 (el) | Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης | |
| CY1109088T1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης | |
| NO20073801L (no) | Atineoplastiske kombinasjoner | |
| ATE398121T1 (de) | Neue synthese von irbesartan | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| EA200600485A1 (ru) | Способ получения производных 2-оксо-1-пирролидина | |
| ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
| NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
| ATE457982T1 (de) | Thiazol-(bi)cycloalkyl-carboxanilide | |
| UA106191C2 (ru) | Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина | |
| TR200503401T1 (tr) | Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları | |
| ATE377594T1 (de) | Oxathiincarboxamide | |
| DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| BR0214445B1 (pt) | processos para a produção de compostos. | |
| EA200600608A1 (ru) | Производные имидазопиридина как ингибиторы индуцируемой no-синтазы | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| WO2005054175A3 (en) | New process for the preparation of nitrooxyderivatives of paracetamol | |
| WO2004096828A3 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes | |
| DE50303586D1 (de) | Methylthiophencarboxanilide | |
| DE602004010530D1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| MXPA05003881A (es) | Preparacion de compuestos triazospiro. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1664007 Country of ref document: EP |